Molecular epidemiology of multi-resistant Escherichia coli

Journal of Hospital Infection

Volumn 43, Issue 1, 1999, Pages 39-48

  Guyot, A ^a   Barrett, S P ^a   Threlfall, E J ^b   Hampton, M D ^b   Cheasty, T ^b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

Antimicrobial drug resistance; Ciprofloxacin; Escherichia coli; Molecular epidemiology

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE; CIPROFLOXACIN; COTRIMOXAZOLE;

ARTICLE; BACTERIAL GENETICS; BACTERIAL INFECTION; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; GEL ELECTROPHORESIS; GEOGRAPHIC AND GEOLOGICAL PHENOMENA; HOSPITAL INFECTION; HUMAN; MOLECULAR BIOLOGY; MULTIDRUG RESISTANCE; PATIENT MONITORING; PLASMID; PULSED FIELD GEL ELECTROPHORESIS; RISK FACTOR; STATISTICAL ANALYSIS; TERMINALLY ILL PATIENT; URINALYSIS; URINARY TRACT INFECTION;

EID: 0032872231     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhin.1999.0637     Document Type: Article

References (17)

1. Threlfall EJ, Cheasty T, Graham A, Rowe B. High level resistance to ciprofloxacin in Escherichia coli. Lancet, 1997; 349: 403.
2. Canawati HN, El-Farra R, Seymour J, Shimashita J, Dunn D, Montgomerie JZ. Ciprofloxacin resistant Escherichia coli emerging in a rehabilitation medical center. Diagn Microbiol Infect Dis 1997; 29: 133-138.
3. Ena J, Lopez-Perezagua M, Martinez-Peinado C, Cia-Barrio M, Ruiz-Lopez I. Emergence of ciprofloxacin resistance in Escherichia coli isolates after wide spread use of flouroquinolones. Diagn. Microbiol Infect Dis 1998; 30: 103-107.
4. Threlfall EJ, Graham A, Cheasty T, Ward LR, Rowe B. Resistance to ciprofloxacin in pathogenic Enterobacteriaceae in England and Wales in 1996. J Clin Path 1997; 50: 1027-1035.
5. Spencer RC. Predominant pathogens found in the European prevalence of infection in intensive care study. Eur J Clin Microbiol Infect Dis; 1996; 15: 281-285.
6. Jarvis WR., Martone WJ. Predominant pathogens in hospital infections. J Antimicrob Chemoth 1992; 29: Suppl A: 19-24.
7. Kado CI, Liu ST. Rapid procedure for detection and isolation of large and small plasmids. J Bact 1988; 145: 1365-1373.
8. Sanders CC, Sanders WE. Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamase. Antimicr Ag Chemother 1979; 15: 792.
9. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad spectrum β-lactamase conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility pattern. Rev Inf Dis 1988; 10: 867-877.
10. Powell NG, Threlfall EJ, Chart H, Rowe B. Subdivision of S. enteritidis PT4 by pulse field gel electrophoresis: potential for epidemiological surveillance. FEMS Microbiology Letters 1994; 119: 193-198.
11. Bukhari SS, Sanderson PJ, Richardson DM, Kaufman ME, Aucken HM, Cookson BD. Endemic cross infection in an acute medical ward. J Hosp Inf 1993; 24: 261-271.
12. Datta N, Faiers MC, Reeves DS, Brumfitt W, Orskov F, Orskov I. R factors in Escherichia coli in faeces after oral chemotherapy in general practice. Lancet 1971; 6: 312-317.
13. Thomas JK, Forrest A, Bhavnani SM, Hyatt JM, Cheng A, Ballow CH, Schentag JJ. Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy. Antimicrob Ag Chemother 1998; 2: 521-527.
14. Wiedemann B, Heisig P. Mechanisms of quinolone resistance. Infection 1994; 22 Suppl 2: s73-s77.
15. Martinez JL, Alonso A, Gomez-Gomez JM, Baquero F Quinolone resistance by mutations in the in chromosomal gyrase genes. Just the tip of the iceberg? J Antimicrob Chemother 1998; 42: 683-688.
16. Muder RR, Brennen C, Goetz AM, Wagener MM, Rihs JD. Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a veterans affairs medical center. Antimicrob Ag Chemother 1991; 35: 256-258.
17. Reed CS, Barrett SP, Threlfall EJ, Cheasty T Control of infection with multiple antibiotic resistant bacteria in a hospital renal unit: the value of plasmid characterization. Epidemiol Infect 1995; 115: 61-70.